Genetische Diagnostik bei Kardiomyopathien

Abstract

Cardiomyopathies often have a genetic etiology. New genetic diagnostic strategies based on next generation sequencing (NGS)-approaches will continuously increase our knowledge about the genetic basis of cardiomyopathies within the following years. Diagnostics and therapy of rare, genetically-induced cardiac diseases increasingly require special cardiac and genetic knowledge. Interestingly, mutations in the same gene or even identical gene mutations can be associated with different cardiomyopathy phenotypes and can exhibit incomplete penetrance or variable expressivity. In the future, the correct interpretation and classification of novel gene variants identified in patients with inherited cardiomyopathy forms will represent a great challenge. Genetic counselling and – if appropriate – subsequent genetic testing for cardiomyopathy patients and their asymptomatic relatives is essential for an early diagnosis of the disease, a prognostic evaluation and possibly for the start of preventive or therapeutic measures.

Kardiomyopathien haben häufig eine genetische Ursache. Neue diagnostische Methoden bieten seit kurzem die Möglichkeit, umfassend und schnell genetische Testungen bei Patienten mit genetischen Herzerkrankungen durchzuführen. Dies wiederum führt zu einem besseren Verständnis dieser Krankheitsbilder und beeinflusst auch zunehmend therapeutische Strategien.

Schlüsselwörter

Kardiomyopathie - DCM - HCM - Genetische Testung - Kardiogenetik

Keywords

cardiomyopathy - DCM - HCM - genetic testing - cardiogenetics

• Literatur

• 1 Elliott P. Andersson B. Arbustini E. et al. Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 2008; 29: 270-276
• 2 Arbustini E. Narula N. Tavazzi L. et al. The MOGE(S) classification of cardiomyopathy for clinicians. J Am Coll Cardiol 2014; 64: 304-318
• 3 Arbustini E. Favalli V. Narula N. et al. Left Ventricular Noncompaction: A Distinct Genetic Cardiomyopathy?. J Am Coll Cardiol 2016; 68: 949-966
• 4 Maron BJ. Towbin JA. Thiene G. et al. Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation 2006; 113: 1807-1816
• 5 Ho CY. Charron P. Richard P. et al. Genetic advances in sarcomeric cardiomyopathies: state of the art. Cardiovasc Res 2015; 105: 397-408
• 6 Punetha J. Hoffman EP. Short read (next-generation) sequencing: a tutorial with cardiomyopathy diagnostics as an exemplar. Circ Cardiovasc Genet 2013; 6: 427-434
• 7 Haas J. Frese KS. Peil B. et al. Atlas of the clinical genetics of human dilated cardiomyopathy. Eur Heart J 2015; 36: 1123-1135a
• 8 Ku CS. Tan EK. Cooper DN. From the periphery to centre stage: de novo single nucleotide variants play a key role in human genetic disease. J Med Genet 2013; 50: 203-211
• 9 McNally EM. Puckelwartz MJ. Genetic Variation in Cardiomyopathy and Cardiovascular Disorders. Circ J 2015; 79: 1409-1415
• 10 Schulze-Bahr E. Klaassen S. Abdul-Khaliq H. et al. Molecular diagnosis for cardiovascular diseases. Dtsch Med Wochenschr 2015; 140: 1538
• 11 McNally EM. Barefield DY. Puckelwartz MJ. The genetic landscape of cardiomyopathy and its role in heart failure. Cell Metab 2015; 21: 174-182
• 12 Ponikowski P. Voors AA. Anker SD. et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 2016; 37: 2129-2200
• 13 Charron P. Arad M. Arbustini E. et al. Genetic counselling and testing in cardiomyopathies: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 2010; 31: 2715-2726
• 14 Meyer S. van der Meer P. van Tintelen JP. et al. Sex differences in cardiomyopathies. Eur J Heart Fail 2014; 16: 238-247
• 15 Ingles J. Doolan A. Chiu C. et al. Compound and double mutations in patients with hypertrophic cardiomyopathy: implications for genetic testing and counselling. J Med Genet 2005; 42: e59
• 16 Maron BJ. Maron MS. Semsarian C. Double or compound sarcomere mutations in hypertrophic cardiomyopathy: a potential link to sudden death in the absence of conventional risk factors. Heart Rhythm 2012; 9: 57-63
• 17 McNally EM. Golbus JR. Puckelwartz MJ. Genetic mutations and mechanisms in dilated cardiomyopathy. J Clin Invest 2013; 123: 19-26
• 18 Kimura A. Molecular genetics and pathogenesis of cardiomyopathy. J Hum Genet 2016; 61: 41-50
• 19 Herman DS. Lam L. Taylor MR. et al. Truncations of titin causing dilated cardiomyopathy. N Engl J Med 2012; 366: 619-628
• 20 van Rijsingen IA. Nannenberg EA. Arbustini E. et al. Gender-specific differences in major cardiac events and mortality in lamin A/C mutation carriers. Eur J Heart Fail 2013; 15: 376-384
• 21 Richard P. Charron P. Carrier L. et al. Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy. Circulation 2003; 107: 2227-2232
• 22 Charron P. Dubourg O. Desnos M. et al. Genotype-phenotype correlations in familial hypertrophic cardiomyopathy. A comparison between mutations in the cardiac protein-C and the beta-myosin heavy chain genes. Eur Heart J 1998; 19: 139-145
• 23 Watkins H. McKenna WJ. Thierfelder L. et al. Mutations in the genes for cardiac troponin T and alpha-tropomyosin in hypertrophic cardiomyopathy. N Engl J Med 1995; 332: 1058-1064
• 24 Kostareva A. Kiselev A. Gudkova A. et al. Genetic Spectrum of Idiopathic Restrictive Cardiomyopathy Uncovered by Next-Generation Sequencing. PLoS One 2016; 11: e0163362
• 25 Towbin JA. Inherited cardiomyopathies. Circ J 2014; 78: 2347-2356
• 26 Pinamonti B. Brun F. Mestroni L. et al. Arrhythmogenic right ventricular cardiomyopathy: From genetics to diagnostic and therapeutic challenges. World J Cardiol 2014; 6: 1234-1244
• 27 van der Smagt JJ. van der Zwaag PA. van Tintelen JP. et al. Clinical and genetic characterization of patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy caused by a plakophilin-2 splice mutation. Cardiology 2012; 123: 181-189
• 28 Ritter M. Oechslin E. Sutsch G. et al. Isolated noncompaction of the myocardium in adults. Mayo Clin Proc 1997; 72: 26-31